Synthetic Drugs

March 28, 2022 | Controlled Substances, Criminal Justice, Drug Courts, Law Enforcement, Opioids, Prescription Drugs, Public Health, Public Safety, Recovery, Reports & Studies, Substance Misuse, Synthetic Drugs

In September 2021, Georgetown University Law Center convened an Opioid Litigation Summit. This convening brought together numerous experts to discuss legal, administrative, and programmatic strategies needed to optimize the impact of proceeds from the opioid litigation. The themes described in this brief emerged from the Summit and can be applied to the opioid litigation as well as future mass tort litigation to address public health crises....

March 2, 2022 | Controlled Substances, Criminal Justice, Drug Courts, Law Enforcement, Opioids, Public Health, Recovery, Reports & Studies, Substance Misuse, Synthetic Drugs

“Stigma” is defined as stereotypes or negative views attributed to a person or groups of people whose characteristics or behaviors are viewed as different from, or inferior to, societal norms. Surveys of public attitudes about various stigmatizing conditions indicate that individuals with a substance use disorder are viewed more negatively than individuals with a mental disorder. This report, released in collaboration with Rulo Strategies LLC, explores efforts to reduce stigma towards individuals with a substance use disorder in public safety and justice settings....

February 16, 2022 | Controlled Substances, Criminal Justice, Fentanyl, Law Enforcement, Opioids, Reports & Studies, Synthetic Drugs, Trafficking

The Commission on Combating Synthetic Opioid Trafficking, established under Section 7221 of the National Defense Authorization Act for Fiscal Year 2020, was charged with examining aspects of the synthetic opioid threat to the United States—specifically, with developing a consensus on a strategic approach to combating the illegal flow of synthetic opioids into the United States. This final report describes items involving the illegal manufacturing and trafficking of synthetic opioids, as well as the deficiencies in countering their production and distribution, and includes action items directed to appropriate executive branch agencies and congressional committees and leadership....

June 29, 2021 | Innovative Initiatives, Opioids, Public Health, Public Safety, Synthetic Drugs

One of the ways in which jurisdictions are combating the epidemic of drug overdoses in communities is through the use of “spike alerts,” that is, targeted messages that notify recipients that there is an unexpected increase in drug-related overdoses in a specific area. The purpose of these notifications is to “reduce injury or death from opioid overdoses during spike events.” ...

June 1, 2021 | Fact Sheets, Fentanyl, Opioids, Public Health, Public Safety, Synthetic Drugs

Smaller than a pencil, and using the same technology as an at-home pregnancy test, fentanyl test strips are disposable, single-use tests that can detect the presence of fentanyl or fentanyl analogs in a substance. This fact sheet sets forth how fentanyl test strips work as a drug checking tool, how they can mitigate risks to people with substance use disorder, and the current challenges with their legality....

April 19, 2021 | Fact Sheets, Fentanyl, Opioids, Public Health, Public Safety, Synthetic Drugs

After domestic production of methamphetamine increased significantly in the 1990s, federal and state authorities took action to address the hazardous conditions left behind in meth labs. Congress passed legislation directing the U.S. Environmental Protection Agency to establish meth decontamination guidelines based on the best available scientific knowledge. Today, the synthetic opioid fentanyl and its analogues cause over twice as many overdose deaths in the United States yearly as meth. Its effects, though similar to morphine or heroin, are 50 to 100 times more powerful, making even small amounts dangerous to users and bystanders alike. Despite this, as of 2021, the scale of federal and state action on fentanyl cleanup is not comparable to that historically taken against meth labs. Fentanyl is a relative newcomer to the scene of illicit drugs in the United States, so scientific authorities and policymakers have had less time to address the issue of clean up. In the interim, the lack of authoritative guidance and policy creates risks, as outlined in this fact sheet....

March 21, 2021 | Controlled Substances, Fact Sheets, Opioids, Prescription Drugs, Public Health, Public Safety, Substance Misuse, Synthetic Drugs

New psychoactive substances (NPS) are “substances of abuse, either in pure form or a preparation, that are not controlled by [international drug conventions], but which may pose a public health threat.” The term “new” (or “novel” in some publications) does not denote a brand new, never-before-seen substance, but a substance that is newly available in the drug market. NPS is a catch-all phrase that includes substances like bath salts, synthetic cannabinoids, synthetic opioids, synthetic cathinones, and other drugs of abuse that are not currently scheduled or controlled. This fact sheet provides general information about new and emerging drugs of abuse....